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Abstract. This study investigates the histological modifications produced by low level laser therapy (LLLT) on
the first day of bone repair, as well as evaluates the LLLT effects on collagen expression on the site of a fracture.
Twenty Wistar rats were distributed into a control group (CG) and a laser group (LG). Laser irradiation of Ga-Al-
As laser 830 nm, 30 mW, 94 s, 2.8 J was performed in five sessions. Animals were euthanized on day 5 post-
surgery. Histopathological analysis showed that LLLT was able to increase deposition of granulation tissue and
newly formed bone at the site of the injury. In addition, picrosirius analysis showed that collagen fiber organi-
zation in the LG was enhanced compared to CG. Microarray analysis demonstrated that LLLT produced an
upregulation type I collagen (COL-I). Immunohistochemical analysis revealed that the subjects that were treated
presented a higher immunoexpression of COL-I. Our findings indicated that LLLT improves bone healing by
producing a significant increase in the expression of collagen genes. © 2016 Society of Photo-Optical Instrumentation
Engineers (SPIE) [DOI: 10.1117/1.JBO.21.8.088001]
Keywords: bone regeneration; low level laser therapy; microarray; collagen.
Paper 160147RR received Mar. 8, 2016; accepted for publication Aug. 2, 2016; published online Aug. 19, 2016.
1 Introduction
Bone is a mineralized connective tissue and it constitutes cells
(osteocytes, osteoblasts, and osteoclasts), inorganic molecules
(calcium, phosphate, and hydroxyapatite), and organic matrix
components (collagen and noncollagenous matrix proteins).1
Collagen is the main component of the organic phase of the
bone tissue.2 It represents more than 90% of the organic matrix
and it plays a central role in bone architecture, supporting bone
mineralization.3–5 Additionally, type I collagen has an important
function during the bone repair process, and it is specially
deposited in granulation tissues by fibroblastic and osteoblastic
cells.6,7 There is evidence that the presence of collagen during
the healing process is responsible for organization of primary
trabecular bone and mature bone.8,9 Likewise, collagen may
be an influential contributor to the strength and stiffness of
the whole bone or bone matrix.10 However, during this complex
process, collagen production can be affected by mutations in the
synthesis of type I collagen genes (COL-I)11 and such mutations
could be related to the decrease of collagen deposition, which
may severely compromise the bone mineralization and its
mechanical capacity to sustain postyield deformation and, there-
fore, absorb energy prior to fracture.12 In addition, there have
been reports showing a direct link between a polymorphism
in the COL-I gene and increased risk of bone fracture.13
In view of the aforementioned, collagen synthesis has a rel-
evant role during the bone repair and, therefore, therapies able to
induce the deposition of collagenous matrix could be beneficial
to treat nonunion fractures.14 One promising treatment is the use
of low level laser therapy (LLLT) due to its stimulatory effect on
tissue metabolism by stimulating cell proliferation,15 stimulating
collagen production by fibroblasts and osteoblasts,16 and accel-
erating the bone repair.17 A recent study demonstrated that
LLLT increased the osteoblastic proliferation and gene expres-
sion of COL-I as well as other osteoblastic markers in osteoblast
cells derived from the midpalatal suture.18 Moreover, Bossini
et al.19 showed that LLLTwas able to increase the collagen dep-
osition in bone repair in osteoporotic rats.
Despite the encouraging data concerning the potential effects
of LLLT to induce newly formed bone, the molecular and cel-
lular mechanisms by which this therapy acts on collagen dep-
osition in the initial periods of repair are not fully understood,
since most studies have evaluated its effects in in vitro study and
in vivo study on intermediate and late periods of bone
healing.8,19 Moreover, there is a lack in the literature of studies
using sophisticated techniques in gene expression analysis (i.e.,
microarrays), which is possible to examine the global gene
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expression and to investigate entire pathways that command bio-
logical processes in the initial periods. Thus, the present study
can provide significant insights of the bone healing process.
Therefore, it was hypothesized that the treatment of bone defects
with LLLT on early stages of fracture healing, which is the most
active period in the recruitment of cells, could stimulate prolif-
eration of fibroblasts and osteoblasts; consequently, collagen
deposition, which can contribute to bone mineralization, may
provide a treatment with additional advantages for clinical
use. Still, this therapy could benefit the treatment of larger
bone defects and fractures with inadequate or interrupted vas-
cularization, a delay in the bone healing process or even a non-
union may happen. Thus, the present study aims to evaluate the
effects of LLLT on collagen expression on the site of bone
defect, 5 days postsurgery. For this purpose, cDNA microarray
analysis was utilized to identify regulated gene expression after
LLLT and the molecular mechanisms involved in the effects.
Also, histological analysis was used to evaluate the area of
newly formed bone in an experimental tibial bone defect
model in rats.
2 Materials and Methods
The animal handling and surgical procedures were strictly
conducted according to the Guiding Principles for the Use
of Laboratory Animals. All procedures were approved by
Institutional Animal Ethics Committee of the Federal
University of São Carlos (Protocol 010/2011).
2.1 Surgical Procedure
Twenty male rats (Rattus norvegicus, Wistar) (350 10 g; 12
weeks) were used in this study. After intraperitoneal anesthesia
with ketamine/xylazine (80∕10 mg∕Kg), a 1-cm incision was
made in the skin to expose the tibia and after that, a standardized
3.0-mm-diameter bone defect was created bilaterally by using a
motorized round drill (BELTEC®, Araraquara-SP, Brazil), under
constant physiologic saline solution irrigation. Thereafter, the
cutaneous flap was joined and sutured with resorbable Vicryl®
5-0 (Johnson & Johnson, St. Stevens-Woluwe, Belgium). In
order to minimize postoperative discomfort, the animals
received analgesia (i.m., 0.05 mg∕kg buprenorphine Temgesic;
Reckitt Benckiser Health Care Limited, Schering Plough,
Hoddesdon, UK) and were returned to their cages. The health
status of the rats was monitored daily.
2.2 Experimental Groups
Animals were randomly divided into two groups of 10 animals
each:
1. Control group (CG): bone defects without any
treatment.
2. Laser group (LG): bone defects treated with laser
830 nm.
2.3 Low Level Laser Therapy
A laser (Thera laser, DMC® São Carlos, Brazil) of 0.6 mm beam
diameter with a continuous wavelength (λ) of 830 nm,
0.028 cm2 spot area, 30 mW, 94 s, 2.8 J, 1.071 W∕cm2, and
100 J∕cm2 was used. Laser irradiation started immediately
after the surgery at one transcutaneous point, above the site
of the injury, and it was performed with an interval of 24 h
between each session, totaling five sessions (Table 1). Laser irra-
diation was performed, at one point per tibia, above the site of
the injury (using the punctual contact technique) and was
applied bilaterally.
2.4 Retrieval of Specimens
Five days postsurgery (24 h after the last laser application),
all animals were euthanized individually by carbon dioxide
asphyxia. Then, both tibias were removed and rapidly dissected.
The left tibias were immediately fixed in 10% formaldehyde
(Merck, Darmstadt, Germany) for 24 h. The right tibias were
frozen in liquid nitrogen and stored in freezer at −80°C until
microarray analysis was carried out.
2.5 Histological Analysis
After fixed, the left tibias were decalcified in 4% diamine tetra-
acetic acid (Merck, Darmstadt, Germany) for 40 days. Then, the
sample was dehydrated in a graded series of ethanol and
embedded in paraffin. Therefore, thin sections (5 μm) were pre-
pared in the longitudinal plane, using a micrometer (Leica RM
—2145, Germany).
2.6 Qualitative Analysis
For the qualitative histopathological analysis, the laminas
were stained with hematoxylin and eosin (H.E stain, Merck,
Darmstadt, Germany). Histopathological evaluation was
performed in a blinded manner, under a light microscope
(Olympus, Optical Co. Ltd, Tokyo, Japan). Any changes in the
bone defect, such as presence of blood clots, fibrin, inflamma-
tory processes, granulation tissue, woven bone, or even tissues
undergoing hyperplastic, metaplastic, and/or dysplastic transfor-
mation were investigated in each animal. In addition, histologi-
cal sections stained by the picrosirius-polarization method were
viewed under polarized light to assess the structural changes in
the neoforming trabecular matrix. This method allows a quali-
tative and quantitative evaluation of the stage of bone matrix
organization based on the birefringence of the collagen fiber
bundles after staining with picrosirius-red and hematoxylin.
Table 1 LLLT parameters.
Laser Ga-Al-As
Equipment Thera laser, DMC® São Carlos, Brazil
Frequency Continuous
Power 30 mW
Power density 1.071W∕cm2
Spot size (cm2) 0.028 cm2
Energy density 100 J∕cm2
Time per point 94 s
Energy 2.8 J
Number of points 1
Method Transcutaneous
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To perform the analysis, the software ImageJ (version 1.36) was
used, and it is possible to identify the brightness of birefringence
by calculating the intensity in “pixels” of color given picrosirius-
red under polarized light. The intensity of pixels is proportional
to the organization of collagen fibers. The collagen fibers are
thicker and strongly birefringent presents stained in shades of
orange to red, which is the most anisotropic collagen.8 Ten fields
were evaluated in the defect region, extension of 100×, allowing
the analysis of the entire focus of the lesion. The values corre-
sponding to each field were added, resulting in the birefringence
of collagen fibers of the bone defect per animal.
2.7 Morphometry Analysis
Sections stained with H.E were used to perform the morphom-
etry of the area of newly formed bone. The analysis was mea-
sured in a blind fashion by two observers, using the image
analysis system Motican 5.0. Five areas of bone defect region
were selected and named C1 (upper region of the border), C2
(right border), C3 (bottom region of the border), C4 (left bor-
der), and C5 (central region of the bone defect). The amount of
newly formed bone was determined in μm2 in each region,
and the total newly formed bone was represented as
C1þ C2þ C3þ C4þ C5.
2.8 Immunohistochemistry
After deparaffinization and rehydration in graded ethanol, each
specimen was pretreated in a Steamer with buffer Diva
Decloaker (Biocare Medical, California) for 5 min for antigen
retrieval. The material was preincubated with 0.3% hydrogen
peroxide in phosphate-buffered saline (PBS) solution for
30 min in order to inactivate endogenous peroxidase and then
blocked with 5% normal goat serum in PBS solution for 20 min.
Three sections of each specimen were incubated with anticolla-
gen (COL-I, Cat. no. sc-59772) polyclonal primary antibody at a
concentration of 1∶1200 (Santa Cruz Biotechnology, Santa
Cruz, California). Incubation was performed overnight at 4°C
in refrigerated environment. Afterward, two washes were
done in PBS for 10 min. Then, incubation of the sections
was performed making use of biotin-conjugated secondary anti-
body anti-rabbit immunoglobulin G (IgG) (Vector Laboratories,
Burlingame, California) at a concentration of 1∶200 in PBS for
30 min. The sections were washed twice with PBS followed by
the application of preformed avidin/biotin complex conjugated
to peroxidase (Vector Laboratories, Burlingame, California) for
30 min. The bound complexes were visible by the application of
a 0.05% solution of 3-3′-diaminobenzidine solution and coun-
terstained with Harris hematoxylin. In order to carry out control
studies of the antibodies, the serial sections were treated with
rabbit IgG (Vector Laboratories, Burlingame, California) at a
concentration of 1∶200 instead of the primary antibody.
Furthermore, internal positive controls were performed with
each staining bath.
Collagen immunoexpression was assessed both qualitatively
(presence of the immunomarkers) and semiquantitatively in five
predetermined fields using a light microscopy (Leica
Microsystems AG, Wetzlar, Germany) according to a previously
described scoring scale ranging from 1 to 4 (1 = absent, 2 =
slight, 3 = moderate, and 4 = intense) for immunohistochemical
analysis.20 The analysis was performed by two observers (PB
and CT), in a blinded manner.
2.9 RNA Sample Preparation
Total RNAwas isolated from the right tibias using the TRIzol®
reagent (Invitrogen, Carlsbad, California) according to the man-
ufacturer’s instructions. After the RNA isolation, the samples
were purified using the illustra RNAspin Mini RNA Kit (GE
Healthcare Life Sciences) according to the manufacturer’s
instructions, quantified by NanoVue spectrophotometer (GE
Healthcare Life Sciences). The quality and integrity of the
total RNA were confirmed with an Agilent 2100 Bioanalyzer
(GE Healthcare Life Sciences) and samples presenting RNA
integrity numbered ≥8 were used for cRNA synthesis.
2.10 Microarray Hybridizations
Agilent whole rat genome microarray 4 × 44 K was used to
perform microarray hybridizations. The labeling and microarray
hybridizations were performed by Agilent using a two-
color microarray-based gene expression analysis (Agilent
Technologies). Briefly, for cDNA synthesis and labeling,
200 ng of total RNA was used. After, cDNA was transcribed
into cRNA, and it was labeled using Agilent low RNA input
fluorescent linear amplification kit (Agilent Technologies,
Santa Clara, California). Then, cRNA labels were purified,
mixed with hybridization buffer, and hybridized to an Agilent
whole rat genome microarray 4 × 44 K for 17 h at 65°C, accord-
ing to the manufacturer’s instructions. The hybridized microar-
rays were washed as the manufacturer’s washing protocol
(Agilent Technologies, Santa Clara, California). After hybridi-
zation, microarrays were sequentially washed: 1 min at room
temperature in GE wash buffer 1 (Agilent Technologies),
then 1 min at 37°C in GE wash buffer 2 (Agilent Technologies),
followed by 10 s in acetonitrile wash (Agilent Technologies),
and finally 30 s in stabilization and drying solution wash
(Agilent Technologies). Afterward, microarray slides were
scanned using GenePix® 4000B microarray scanner (Molecular
Devices) while simultaneously scanning the Cy3 and Cy5 chan-
nels at a resolution of 5 μm. Laser was set at 100% and PMT
gain was automatically adjusted for each slide using the program
GenePix 4000B according to the intensity of the signal in
each array.
2.11 Microarray Data Analysis
Microarray data analysis was performed as described by Castro
et al.21 Data files were generated using Agilent’s feature extrac-
tion software (version 11.5, Agilent) and the default parameters,
which include Lowess-based signal normalization. The dye-nor-
malyzed values generated in the feature extraction data files
were used to upload the software express converter (version
2.1, TM4 available at Ref. 22), which conveniently converts
the Agilent file format to MeV (multiexperiment view) file for-
mat compatible to the TM4 softwares for microarray analysis
(available at Ref. 23). The MeV files were then uploaded in
the MIDAS software where the resulting data were averaged
from replicated genes on each array, from three biological rep-
licates, taking a total of three intensity data points for each gene.
The MeV files generated were then loaded in MeV software
where differentially expressed genes were identified using
one-class t-test (p < 0.01). Significantly different genes were
those whose mean log2 expression ratio over all included sam-
ples was statistically different from 0, which indicates the
absence of gene modulation.
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2.12 Functional Analyses Using Ingenuity Pathways
Analysis Software
A network analysis was performed using the ingenuity path-
ways analysis (IPA) (Ingenuity Systems)24 algorithm. The
lists of differentially expressed genes were entered into the
IPA software to explore relevant biological networks and to
assess interactions with other genes. A hypothetical global
gene interaction network was constructed, showing the most rel-
evant direct and indirect connections of genes found to be regu-
lated under LLLT.
2.13 Quantitative Real-Time Polymerase Chain
Reaction
Real-time polymerase chain reaction (RT-PCR) was performed
to confirm the differential expression results obtained by the
microarray experiments. Total RNA was extracted and purified
using the experimental protocols described above. One micro-
gram of total RNA was reverse-transcribed into cDNA and fol-
lowed by RT-PCR amplification using rats gene-specific primers
(Table 2), which were designed by primerexpress software
(Applied Biosystems, Foster City, California). The optimized
PCR conditions were: initial denaturation at 94°C for 10 min,
followed by 40 cycles consisting of denaturation at 94°C for
15 s, annealing at 60°C for 1 min, and extension at 72°C for
45 s, with a final extension step at 72°C for 2 min. Negative-
control reactions with no template (deionized water) were
also included in each run. All samples were amplified simulta-
neously in duplicate in one assay run. Analysis of relative gene
expression was performed using the 2-ΔΔCT method. RPS18
was used as a housekeeping gene to normalize our expression
data.
2.14 Statistical Analysis
The normality of all variables distribution was verified using
Shapiro–Wilk’s W test. For morphometric and immunohisto-
chemical analysis, comparisons among groups were performed
using t-test. STATISTICAversion 7.0 (data analysis software sys-
tem—StatSoft Inc.) was used to carry out the statistical analysis.
Values of p < 0.05 were considered statistically significant.
3 Results
3.1 Histological Analysis
An overview of the representative histological sections of all
experimental groups is shown in the Fig. 1. For CG, 5 days
after the surgery, the bone defect area was filled by inflamma-
tory infiltrate, granulation tissue, and immature newly formed
bone [Fig. 1(a)]. At the same experimental period, for the
LG, inflammatory infiltrate was presented only in the central
region of the defect. The rest of the defect was filled by
some areas of granulation tissue and bone ingrowth [Fig. 1(b)].
In addition, picrosirius analysis showed that collagen fiber
organization in the LG was enhanced compared to the CG, dem-
onstrated by the increased thickness of the colored areas
[Figs. 2(a) and 2(b)].
3.2 Morphometric Analysis
Figure 3 shows that the animals exposed to laser therapy pre-
sented a statistically significant increase in the newly formed
bone at the defect area compared to the CG (Fig. 2).
3.3 Immunohistochemical Analysis
Qualitative immunohistochemical analysis demonstrated that
COL-I expression was detected in granulation tissue, osteoblast,
and bone matrix for both groups [Fig. 4(a)]. However, for the
LG, the immunoreactivity of COL-I was mainly observed in
osteoblast and newly formed bone, when compared to the CG.
Semiquantitative analysis revealed a significant increase in
COL-I immunoexpression for the LG compared to the CG,
5 days after surgery [Fig. 4(b)].
3.4 Microarray Analysis
In order to examine genes modulated by LLLT during bone
repair on a genome-wide basis, microarray expression profiling
was carried out on skeletal tissues. Thus, a total of 382 genes
modulated were identified after laser irradiation. It was found
that 127 genes downregulate and 255 genes upregulate.
3.5 Functional Network Analysis
In order to analyze these expression data, a reliable new bioin-
formatics approach, IPA (Ingenuity, California) was applied to
set up a potential network, which is based on the regulated genes
in order to identify the molecular events and further unveil the
molecular mechanisms regulating the processes of LLLT effects
in bone. In order to start building networks, IPA queries the
ingenuity pathways knowledge base for interactions between
the regulated genes and the genes stored in the database. The
networks were identified and ranked according to the score
p-score ¼ − log 10 (p-value). The score takes into account
Table 2 Real-time PCR primers.
Gene Forward primer Reverse primer
RPS18 GTGATCCCCGAGAAGTTTCA AATGGCAGTGATAGCGAAGG
PTGER2 GAACTGCGAGAGTCGTCAGTATCTC CCCCGGCCGTGAACAT
IL1R1 AAGTGGAATGGGTCGGAAATT TGAAGGGTGTTCCAAAAACTGA
ANGPT4 GGCATCTACTATCCGGTTCATCA CATGCGTGTGCCATGCA
PDGFD TATGCTCATTGGATGCCTTGTC TGCTGCTATCGGGACACTTTT
FGF2 AAGGATCCCAAGCGGCTCTA CGGCCGTCTGGATGGA
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the number of network eligible molecules in the network and its
size, as well as the total number of network eligible molecules
analyzed and the total number of molecules in the ingenuity
knowledge base, which could potentially be included in net-
works. A score > 3 (p < 0.001) indicates a >99.9% confidence
that a gene network was not generated by chance alone.
Furthermore, the IPA score can be interpreted as the probability
of getting a network containing at least the same number of net-
work eligible molecules by chance when randomly picking
genes that can be in networks from the ingenuity knowledge
base. Thus, the major biological processes identified for
increased gene expressions related to inflammatory responses,
connective tissue development, and skeletal and muscular sys-
tem activity were investigated (Table 3).
In view of the aforementioned, several functional groupings
of differentially expressed genes were identified. The up- and
downregulated connective tissue development and function
genes were further examined and revealed some COX-2-related
genes, interleukins, growth factors, angiogenic, and osteogenic
signaling and provided an initial analysis. However, this report
focused on expression of bone collagen of early events of bone
healing and the downregulation and upregulation connective tis-
sue genes were examined and revealed the significantly upregu-
lated of type I collagen gene. The altered expression of this gene
suggests that LLLT acts on the stimulation of fibriblasts and
osteoblast, consequently in bone forming.
3.6 Validation of Microarray Data by Real-Time
Polymerase Chain Reaction
Quantitative real-time PCR (qPCR) is a commonly used valida-
tion tool for confirming gene expression results obtained from
microarray analysis. Thus, qPCR was performed to validate our
results of the microarray assays. The genes were selected
according to the canonical pathway analysis and the expression
profiles of the genes confirmed the microarray results. Our PCR
results were consistent with the pathway prediction, showing
that the relative mRNA levels of those osteogenic genes were
modulated by LLLT (Fig. 5).
Fig. 1 Representative sections of hematoxylin and eosin stain. Newly formed bone (Nb), granulation
tissue (G), inflammatory infiltrate (In). (a) CG = control group, (b) LG = laser group. Scale bar ¼ 150 μm.
Fig. 2 Representative sections of picrosirius red stain. Photomicrographs using polarized light illustrating
the collagen. Arrow indicates the yellowish and reddish birefringent zones. (a) CG = control group, (b) LG
= laser group. Scale bar ¼ 150 μm.
Fig. 3 Means and SD of the newly formed bone tissue of bone area
(μm2) of the defect after treatments. Significant differences of
p < 0.001 are represented by a single asterisk (*).
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4 Discussion
This study aimed to investigate the histological modifications
produced by LLLT and to study the collagen deposition in
the initial stages of bone healing. The main findings showed
that LLLT increased the deposition of granulation tissue and
newly formed bone. In addition, the COL-I immunoexpression
was also increased by LLLT. Furthermore, our results showed
that LLLT produced a significant increase in the expression of
type I collagen genes.
Several studies have shown that LLLT is able to induce cell
proliferation, accelerate tissue metabolism, and produce colla-
gen synthesis on the process of tissue repair.20,25–27 This
study suggest that LLLT was able to attract the osteoprogenitor
cells and induce their differentiation into fibroblasts and osteo-
blasts, thus promoting collagen deposition in early phases of the
bone repair process. Collagen deposition was investigated by
picrosirius analysis, which allowed the correlation between
the growth of primary (trabecular) bone area with the collagen
fibers deposition. This coloration is used to investigate the red-
dish and yellowish birefringence, which is indicative of type I
and III collagen. These results corroborate with others studies
that used picrosirius analysis and demonstrated that LLLT
stimulated the growth of the trabecular area and hastened the
organization of matrix collagen during the first week of bone
repair.8 At the same way, Bossini et al.19 demonstrated that
irradiated animals presented a higher deposition of collagen
fibers and a better organization of these fibers when compared
to the CG.
In parallel with these changes, the morphometric analysis
showed that the LG was capable of increasing the deposition
of newly formed bone, when compared to the CG. These find-
ings are in line with the results of Fernandes et al.,28 which
showed that LLLT induced a recruitment of inflammatory
cells and increased newly formed bone in the initial phases
of bone consolidation. Additionally, effects of LLLT on the col-
lagen synthesis were also demonstrated by the increased immu-
noexpression of COL-I in the LG when compared with the CG.
Also, recent studies demonstrated that LLLT produced an
increase of gene expression of COL-I.17,18 Likewise, several
studies showed that LLLT increased COL-I immunoexpression
during the early phases of tissue repair.29,30
Collagens constitute a family of proteins, with more than 27
forms, and in the bone tissue the types I, II, III, V, VI, and XI
collagen are present.10,31,32 However, it is well known that the
Fig. 4 (a) representative sections of COL-I immunohistochemistry. Newly formed bone (Nb), granulation
tissue (G), osteoblast, and (Ob) intact bone (*). (b) means and standard error of the mean of scores immu-
nohistochemistry of COL-I. Significant differences of p < 0.05 are represented by a single asterisk (*).
Table 3 Top genetic network.
Network functions Score
Day 5
Connective tissue development and function 20
Skeletal and muscular system development and
function, cell-to-cell signaling and interaction
20
Cell-to-cell signaling and interaction, inflammatory
response, and gene expression
17
Cell cycle, DNA replication, recombination, and repair,
cellular assembly, and organization
15
Cell morphology, cellular assembly and organization,
and cellular development
12
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type I collagen has the most abundant and important collagen in
the bone tissue.10 In order to further investigate the action of the
LLLTon bone repair, members of the collagen family expressed
locally during the bone repair process were evaluated. In the
present study, microarray analysis showed that LLLT produced
an upregulation of type I collagen gene. This result suggests that
the increase in gene expression of collagen, in special type I,
could have contributed to the healing process and accelerated
the bone repair process, once COL-I is the major structural pro-
tein and the main extracellular matrix protein for
calcification.10,33 Likewise, previous studies demonstrated that
LLLT (830 nm) increased the osteoblastic proliferation and
increased the expression of osteoblastic markers, such as
gene expression of COL-I, runt-related transcription factor 2,
osteocalcin, and alkaline phosphatase.18 Moreover, other studies
showed that LLLT (904 and 830 nm) could induce enhanced
repair by increasing the expression of procollagen type I and
III mRNA34,35 and increasing collagen synthesis.19
It is known that the bone repair process constitutes a dynamic
tissue reaction, which comprises different phenomena, such as
inflammation, cell proliferation, and synthesis of elements of the
extracellular matrix, including collagen. Synthesis of collagen
fibers plays a central role in bone architecture, once the bone
mineral crystals are deposited among collagen fibrils, which
contribute to the bone mineralization.3,5,36 Mutations in the
amino acid sequence of collagen, as in osteogenesis imperfecta,
can seriously impair the formation, orientation, and organization
of the apatite crystals, which significantly increases the brittle-
ness of bone.37 Therefore, it is clear that there is a relationship
between the fibril structure and mineral formation.36
According to several authors,19,35,38,39 some main biostimu-
lation effects of LLLT in the process of tissue repair include
induction of mitotic activity of epithelial cells and fibroblasts,
and the stimulation of collagen production by those cells.
There are several mechanisms through which LLLT could
induce mitotic activity of fibroblasts. LLLT stimulates the pro-
duction of basic fibroblast growth factor (bFGF), which is a
multifunctional polypeptide secreted by fibroblasts. It is not
only able to induce fibroblast proliferation but also differentia-
tion, and it affects the immune cells that secrete cytokines and
other regulatory growth factors of fibroblasts. In addition, it has
been reported that LLLT increases the levels of ascorbic acid in
fibroblasts, thus increasing the formation of hydroxyproline and,
consequently, the production of collagen, since ascorbic acid is a
cofactor required for hydroxylation of proline during collagen
synthesis.40
In addition, it is possible to suggest that these results could be
related to the laser parameters used in the present study. There
are reports in the literature proposing that the wavelength of
830 nm, which was used in this study, could be advantageous
to induce the increase fibroblast cell proliferation that could
increase the collagen synthesis.41,42 Similarly, it is possible to
suggest that the laser energy (2.8 J) used in this study had a
positive result on bone metabolism at the site of the injury.
Our results corroborate those of Fernandes et al. and Bossini
et al. that used 830-nm laser, at the energy of 2.8 and 3.4 J,
respectively, to investigate the effects of LLLT during the proc-
ess of bone healing and showed that LLLT was able to induce
osteogenic genes and collagen deposition. Our results demon-
strated that LLLT could increase the newly formed bone.
These findings could be related with COL-I expression once
the literature demonstrated that production of type I collagen
is one of the earliest events associated with osteoblastic
differentiation.43 Thus, it could propose that the upregulation
of this gene may indicate the presence of more active fibroblasts
and osteoblasts, which can be related to the increase of granu-
lation tissue and newly formed bone observed in the histological
analysis in the LLLT group.
Fig. 5 Validation of up- and downregulated gene expression by real-time RT-PCR in irradiated animals.
The results are normalized as a ratio of each specific mRNA signal to the RPS18 gene signal within the
same sample and the values expressed. The significance of differences was determined using Student’s
t-test. *p < 0.05.
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Taken together, the results of the present study showed that
LLLT might be a promising therapy to improve bone consoli-
dation in the initial period of repair by modulating the expres-
sion of COL-I, which may contribute to stimulate bone cells and
increase newly formed bone. As this study was limited to a
short-term evaluation, information on the influence of LLLT
on gene expression in long-term analysis still needs to be
provided.
5 Conclusion
The results found in the present study indicate that LLLT was
efficient in modulating the inflammatory process, stimulating
bone metabolism, and accelerating new bone formation and col-
lagen deposition at the site of the injury. In addition, LLLT pro-
duced a significant increase in the expression of COL-I
expression, which contributes to the bone mineralization.
This fact may explain mechanisms that LLLT acts on bone heal-
ing. Therefore, these data highlight the potential of LLLT to be
used as a therapeutic approach for bone regeneration.
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